Helicobacter pylori treatment: a role for probiotics?

Alessandro Armuzzi, Giovanni Battista Gasbarrini, Antonio Gasbarrini, Filippo Cremonini, Simona Di Caro, Luca Santarelli, F Canducci

Risultato della ricerca: Contributo in rivistaArticolo in rivista

30 Citazioni (Scopus)

Abstract

Many new therapeutic strategies are studied to improve Helicobacter pylori eradication rate. Probiotics are live microorganisms which, upon administration, may interact with the human microflora and positively affect the health status. The use of probiotics in the field of H. pylori infection has been proposed for improving eradication rate and tolerability and for compliance of multiple antibiotic regimens used for the infection. Results from laboratory studies and from clinical trials seem to confirm the expectancies, but there is lack of standardization in terms of type of probiotic strain used, dosage and timing of supplementation. Before further ongoing trials and future studies will clarify these points, probiotics could remain a useful adjunct to standard anti-H. pylori therapies, but cannot take the place of other validated options.
Lingua originaleEnglish
pagine (da-a)144-147
Numero di pagine4
RivistaDigestive Diseases
Volume19
Stato di pubblicazionePubblicato - 2001

Keywords

  • Anti-Bacterial Agents
  • Combined Modality Therapy
  • Helicobacter Infections
  • Helicobacter pylori
  • Probiotics

Fingerprint

Entra nei temi di ricerca di 'Helicobacter pylori treatment: a role for probiotics?'. Insieme formano una fingerprint unica.

Cita questo